Deep Genomics
Deep Genomics is a leading artificial intelligence (AI) driven drug discovery and development company. They leverage deep learning to understand how genetic variations impact RNA biology and to design novel RNA-based therapies for genetic diseases. The company aims to transform the drug discovery process by integrating AI with genomics and RNA biology to identify and optimize therapeutic candidates for conditions that previously had no effective treatments.
About Us
Founded in 2014 by Brendan Frey, Deep Genomics pioneered the application of deep learning to genetic medicine. The company has developed a sophisticated AI Workbench that combines massive biological datasets with advanced algorithms to predict the impact of genetic changes on RNA and to design precise RNA-based drug candidates. Based in Toronto, Canada, Deep Genomics is dedicated to bringing life-changing genetic medicines to patients through its innovative AI platform.
Vision
To build a world where people are free from genetic disease.
Mission
To bring life-changing genetic medicines to patients by leveraging the power of artificial intelligence.
Culture
Deep Genomics fosters a culture of innovation, scientific rigor, and collaboration, driven by a shared passion for making a tangible impact on patients' lives. The company emphasizes a multidisciplinary approach, bringing together experts in AI, machine learning, biology, genetics, and drug development to solve complex challenges. It encourages continuous learning, open communication, and a patient-centric mindset.
Specialties & Industries
Open Positions
No open positions at the moment
Check back later for new opportunities